Evidence map›Paper›PMID 28102763›Full record

ArticleVirulence2017

The best defense is a good (Protease) offense: How Pseudomonas aeruginosa evades mucosal immunity in the lung.

Lisa A Miller

Abstract readEditorialComment
In one paragraph

Article in Virulence, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Lisa A Millera Department of Anatomy , Physiology, and Cell Biology, UC Davis School of Veterinary Medicine & California National Primate Research Center , Davis , CA , USA.

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
EPIGENETIC PROGRAMMING OF INNATE IMMUNITY IN PEDIATRIC AIRWAY EPITHELIUMR21AI116129 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MILLER, LISA A · 2015 to 2016
$439k
NIAID NIH HHS R21 AI116129NIH HHS P51 OD011107
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunity, MucosalPseudomonas aeruginosaHumansImmunity, InnateLungPeptide HydrolasesPseudomonas InfectionsPeptide HydrolasesIL-22lungmucosaPseudomonas

Identifiers

PMID28102763
PMCPMC5626340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.